Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07240584 | Exercise Prehabilitation of Breast Cancer(Prehab of BC) | completed | N/A | 30 | University of Health Sciences Balikesir Hospital Eduation and ResearchOTHER_GOV | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05472532 | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture)(INOVOLINE) | completed | N/A | 101 | Hospices Civils de LyonOTHER |
| 1 |
| Nov 20, 2025 |
| clinicaltrials |
| NCT01626950 | Living Conditions and Breast Cancer | completed | — | 684 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT03787966 | Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program(ATOPE) | completed | N/A | 100 | Universidad de GranadaOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT03079011 | PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection(PADA-1) | completed | Phase 3 | 1,017 | UNICANCEROTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT04583124 | Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)(ATENTO) | completed | N/A | 42 | Universidad de GranadaOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06120439 | Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy | completed | N/A | 96 | Jun ZhangOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06408038 | Are CK+/CD45+ Double-Positive Circulating Cells of Tumor-origin? Characterization in METAstatic Breast Cancer(DP METABREAST) | completed | N/A | 60 | Institut Claudius RegaudOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05573022 | Impact of a Patient Decision Aid Intervention(IMPACTT) | completed | N/A | 274 | Vejle HospitalOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT05950685 | Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments | completed | — | 1,602 | Ifat KleinOTHER | 1 | Nov 17, 2025 | clinicaltrials |
| NCT03371017 | A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer(IMpassion132) | completed | Phase 3 | 595 | Hoffmann-La RocheINDUSTRY | 28 | Nov 12, 2025 | clinicaltrials |
| NCT04647487 | A Study of LY3484356 in Women With Breast Cancer Before Having Surgery(EMBER-2) | completed | Phase 1 | 87 | Eli Lilly and CompanyINDUSTRY | 6 | Nov 12, 2025 | clinicaltrials |
| NCT03280563 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer(MORPHEUS HR+BC) | completed | Phase 1 / Phase 2 | 144 | Hoffmann-La RocheINDUSTRY | 3 | Nov 10, 2025 | clinicaltrials |
| NCT06133348 | Promoting Resilience in Women With Breast Cancer(PRISM) | completed | N/A | 43 | University of Alabama at BirminghamOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT02593175 | Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC | completed | Phase 2 | 43 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2025 | clinicaltrials |
| NCT03396445 | Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001) | completed | Phase 1 | 182 | Merck Sharp & Dohme LLCINDUSTRY | 7 | Nov 5, 2025 | clinicaltrials |
| NCT05978232 | NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients | completed | N/A | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 5, 2025 | clinicaltrials |
| NCT06106282 | Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) | completed | — | 105 | Mayo ClinicOTHER | 1 | Oct 31, 2025 | clinicaltrials |
| NCT07223476 | Treatment Landscape and Real-World Dosing Patterns With CDK4/6 Inhibitors for Breast Cancer in Portugal(PORTRAIT) | completed | — | 1,926 | Novartis PharmaceuticalsINDUSTRY | 1 | Oct 31, 2025 | clinicaltrials |
| NCT03620643 | Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours(ROLo) | completed | Phase 2 | 33 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 30, 2025 | clinicaltrials |
| NCT03036488 | Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) | completed | Phase 3 | 1,174 | Merck Sharp & Dohme LLCINDUSTRY | 21 | Oct 29, 2025 | clinicaltrials |
| NCT04821375 | Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers | completed | Early Phase 1 | 16 | Carol Fabian, MDOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT07221071 | Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study)(Prepare) | completed | N/A | 42 | Endeavor HealthOTHER | 1 | Oct 27, 2025 | clinicaltrials |
| NCT04568902 | Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | completed | Phase 1 | 33 | Eisai Co., Ltd.INDUSTRY | 1 | Oct 23, 2025 | clinicaltrials |
| NCT03822468 | Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer(AMALEE) | completed | Phase 2 | 376 | Novartis PharmaceuticalsINDUSTRY | 23 | Oct 16, 2025 | clinicaltrials |
| NCT05082610 | A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors | completed | Phase 1 | 48 | Hummingbird BioscienceINDUSTRY | 1 | Oct 16, 2025 | clinicaltrials |
| NCT02819362 | Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound(IRM-sein) | completed | — | 70 | Institut BergoniéOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT02510456 | Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging(DOSI) | completed | — | 24 | Boston Medical CenterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05945927 | A Study to Evaluate the Safety and Effectiveness of Trastuzumab Emtansine (T-DM1) as Therapy in Chinese Participants With HER2 Positive Advanced Breast Cancer | completed | — | 178 | Hoffmann-La RocheINDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT04023110 | Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab(CCTGuide Pilot) | completed | Phase 1 | 68 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Oct 9, 2025 | clinicaltrials |
| NCT06180460 | CALM: Managing Distress in Malignant Brain Cancer | completed | N/A | 60 | Virginia Commonwealth UniversityOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT06572800 | Tka Assay for CDK4/6i | completed | N/A | 34 | Yale UniversityOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT07211451 | Axillary Nodal Burden in HER2+ and TNBC | completed | — | 1,571 | Gangnam Severance HospitalOTHER | 1 | Oct 8, 2025 | clinicaltrials |
| NCT04863443 | Nonlinear Elasticity Mapping of Breast Masses | completed | — | 172 | Mayo ClinicOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT06975371 | Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i | completed | — | 1,415 | Daiichi SankyoINDUSTRY | 1 | Oct 7, 2025 | clinicaltrials |
| NCT00462696 | MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer(ISNA-Sein) | completed | N/A | 16 | Institut BergoniéOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05599334 | A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib(NEAR) | completed | — | 111 | Pierre Fabre MedicamentINDUSTRY | 5 | Oct 6, 2025 | clinicaltrials |
| NCT07199556 | Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.(DOLFLEX) | completed | N/A | 30 | Arafarma Group, S.A.INDUSTRY | 1 | Oct 3, 2025 | clinicaltrials |
| NCT02216162 | PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program(PROACTIVE) | completed | N/A | 12 | Hospices Civils de LyonOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04343807 | Effectiveness of Ultrasound Guided PECS Block on Opioid Consumption and Patient Satisfaction Through Adequate Pain Control Following Breast Cancer Surgery. | completed | N/A | 70 | Aga Khan UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05921331 | RJBC-APP and Breast Cancer Treatment Compliance | completed | N/A | 540 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06199050 | The Effect of 360° Virtual Reality Movies on Fear and Anxiety(ENGAGE) | completed | N/A | 292 | Maastricht Radiation OncologyOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT00210223 | Radiofrequency of Breast Cancers in Non Surgical Patients(RF-SEIN) | completed | N/A | 21 | Institut BergoniéOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT01754597 | Natriuretic Peptide Concentrations of B-type (BNP) During Anesthesia in Patients Previously Sensitized to Anthracyclines(PEP-NAT-B) | completed | N/A | 54 | Institut BergoniéOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT06580743 | Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer | completed | — | 52 | University of MinnesotaOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT01982448 | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer | completed | Phase 2 | 147 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT03367208 | Study of Metabolites Markers in Adjuvant Breast Cancer(EMMEEA) | completed | — | 52 | Centre Antoine LacassagneOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT03264547 | A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + Trastuzumab | completed | Phase 3 | 446 | Japan Breast Cancer Research GroupOTHER | 1 | Sep 29, 2025 | clinicaltrials |
| NCT04365569 | Evaluating the Effectiveness of an Individualized Nutrition and Physical Activity Counseling Program | completed | N/A | 78 | Case Comprehensive Cancer CenterOTHER | 1 | Sep 29, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Nov 21, 2025source: clinicaltrials